IE35897B1 - Azapurinones - Google Patents

Azapurinones

Info

Publication number
IE35897B1
IE35897B1 IE1583/71A IE158371A IE35897B1 IE 35897 B1 IE35897 B1 IE 35897B1 IE 1583/71 A IE1583/71 A IE 1583/71A IE 158371 A IE158371 A IE 158371A IE 35897 B1 IE35897 B1 IE 35897B1
Authority
IE
Ireland
Prior art keywords
compounds
prepared
reaction
reacting
triazole
Prior art date
Application number
IE1583/71A
Other languages
English (en)
Other versions
IE35897L (en
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of IE35897L publication Critical patent/IE35897L/xx
Publication of IE35897B1 publication Critical patent/IE35897B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IE1583/71A 1970-12-15 1971-12-14 Azapurinones IE35897B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB5955270 1970-12-15
GB5955670 1970-12-15
GB4975671A GB1338235A (en) 1970-12-15 1971-10-26 Azapurinones
GB5345771 1971-11-17

Publications (2)

Publication Number Publication Date
IE35897L IE35897L (en) 1972-06-15
IE35897B1 true IE35897B1 (en) 1976-06-23

Family

ID=27449009

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1583/71A IE35897B1 (en) 1970-12-15 1971-12-14 Azapurinones

Country Status (25)

Country Link
US (1) US3987160A (xx)
JP (1) JPS5310599B1 (xx)
AR (4) AR192602A1 (xx)
AT (4) AT317211B (xx)
AU (1) AU458277B2 (xx)
BE (1) BE776683A (xx)
BG (3) BG20806A3 (xx)
CH (5) CH550814A (xx)
DD (1) DD95007A5 (xx)
DE (1) DE2162096A1 (xx)
DK (1) DK141249B (xx)
FI (1) FI53457C (xx)
FR (1) FR2118078B1 (xx)
GB (1) GB1338235A (xx)
HK (1) HK42177A (xx)
HU (1) HU165079B (xx)
IE (1) IE35897B1 (xx)
IL (1) IL38364A (xx)
IS (1) IS1099B6 (xx)
LU (1) LU64457A1 (xx)
NL (1) NL174943C (xx)
NO (1) NO134257C (xx)
OA (1) OA03930A (xx)
SE (1) SE393381B (xx)
ZM (1) ZM18971A1 (xx)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1493685A (en) * 1970-12-15 1977-11-30 May & Baker Ltd 8-azapurinones
BE792648A (fr) * 1971-12-13 1973-06-12 May & Baker Ltd Derives de l'isoquinoleine
FR2406638A1 (fr) * 1977-10-21 1979-05-18 May & Baker Ltd Nouvelles aza-8 purinones-6, leur preparation et les compositions pharmaceutiques les contenant
EP0007727B1 (en) * 1978-07-24 1983-11-30 Beecham Group Plc Benzopyranotriazoles, preparation of these compounds and pharmaceutical composition containing them
JPS60226887A (ja) * 1984-04-25 1985-11-12 Dai Ichi Seiyaku Co Ltd トリアゾロピリミジン誘導体
CA1303037C (en) * 1987-02-02 1992-06-09 Smith Kline & French Laboratories Limited Purinone derivatives as bronchodilators vasodilators and anti-allergic agents
EP0288431B1 (de) * 1987-04-07 1992-08-19 Ciba-Geigy Ag 3H-1,2,3-Triazolo[4,5-d]pyrimidine
US5204353A (en) * 1987-04-07 1993-04-20 Ciba-Geigy Corporation 3-benzyl-3H-1,2,3-triazolo[4,5-d]pyrimidines, compositions thereof, and method of treating epilepsy therewith
FR2618073B1 (fr) * 1987-07-16 1990-09-07 Pf Medicament Comprimes de type a matrice hydrophile a base de salbutamol et leur procede de preparation
GB8817651D0 (en) * 1988-07-25 1988-09-01 Smith Kline French Lab Chemical compounds
DE4211239C2 (de) * 1992-04-03 1995-11-16 Max Planck Gesellschaft Arzneimittel gegen Herz-Kreislauf-Erkrankungen
US5734053A (en) * 1992-06-26 1998-03-31 Pfizer Inc Purinone antianginal agents
GB9213623D0 (en) * 1992-06-26 1992-08-12 Pfizer Ltd Therapeutic agents
GB9311920D0 (en) 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6080428A (en) * 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US20080045573A1 (en) * 1993-09-20 2008-02-21 Bova David J Methods and Sustained Release Nicotinic Acid Compositions for Treating Hyperlipidemia
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6129930A (en) * 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
GB9404485D0 (en) * 1994-03-09 1994-04-20 Cancer Res Campaign Tech Benzamide analogues
PT1049695E (pt) 1997-11-12 2002-07-31 Bayer Ag Imidazotriazinonas 2-fenil substituidas enquanto inibidores de fosfodiesterase
DE19838705A1 (de) * 1998-08-26 2000-03-02 Bayer Ag Neue Dihydro-(1,2,3)-triazolo-[4,5-d]pyrimidin-7-one
IT1318674B1 (it) * 2000-08-08 2003-08-27 Nicox Sa Faramaci per l'incontinenza.
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
DE102005009240A1 (de) 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
DK2170930T3 (da) 2007-06-04 2012-11-05 Synergy Pharmaceuticals Inc Agonister af guanylatcyclase, anvendelige til behandlingen af gastrointestinale sygdomme, inflammation, cancer og andre sygdomme
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
ES2664873T3 (es) 2011-03-01 2018-04-23 Synergy Pharmaceuticals Inc. Proceso de preparación de agonistas de guanilato ciclasa C
EP2958577A2 (en) 2013-02-25 2015-12-30 Synergy Pharmaceuticals Inc. Guanylate cyclase receptor agonists for use in colonic cleansing
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
KR102272746B1 (ko) 2013-06-05 2021-07-08 보슈 헬스 아일랜드 리미티드 구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법
KR20220147691A (ko) 2013-08-09 2022-11-03 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
MX2019006938A (es) 2016-12-14 2019-09-06 Respira Therapeutics Inc Metodos y composiciones para trataminto de hipertension pulmonar y otros trastornos del pulmon.
KR20210119485A (ko) 2019-01-24 2021-10-05 프로메테우스 바이오사이언시즈, 인크. Gpr35 조절제
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス, インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ
CA3186635A1 (en) * 2020-07-23 2022-01-27 Robert Higuchi Therapeutic agents targeting gpr35

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2407204A (en) * 1944-07-22 1946-09-03 American Cyanamid Co Triazolo (d) pyrimidines and methods of preparing the same
US2993039A (en) * 1959-11-06 1961-07-18 Upjohn Co Preparing nu-glycosides of aldose and ketose sugars

Also Published As

Publication number Publication date
AR192602A1 (es) 1973-02-28
AT315838B (de) 1974-06-10
NL174943B (nl) 1984-04-02
IL38364A (en) 1975-08-31
BG20805A3 (xx) 1975-12-20
AR199467A1 (es) 1974-09-09
NO134257B (xx) 1976-05-31
HK42177A (en) 1977-08-19
NL7117142A (xx) 1972-06-19
DE2162096A1 (de) 1972-07-06
CH555351A (fr) 1974-10-31
BG20807A3 (xx) 1975-12-20
FI53457C (fi) 1978-05-10
JPS5310599B1 (xx) 1978-04-14
OA03930A (fr) 1975-08-14
AR199468A1 (es) 1974-09-09
LU64457A1 (xx) 1972-08-23
CH546779A (fr) 1974-03-15
AR192689A1 (es) 1973-02-28
IE35897L (en) 1972-06-15
AT315839B (de) 1974-06-10
HU165079B (xx) 1974-06-28
BG20806A3 (xx) 1975-12-20
AU3686771A (en) 1973-06-21
AU458277B2 (en) 1975-02-20
FI53457B (xx) 1978-01-31
IS1099B6 (is) 1982-11-18
DE2162096C2 (xx) 1988-02-11
US3987160A (en) 1976-10-19
FR2118078A1 (xx) 1972-07-28
NO134257C (xx) 1976-09-08
CH552610A (fr) 1974-08-15
AT317211B (de) 1974-08-26
DD95007A5 (xx) 1973-01-12
GB1338235A (en) 1973-11-21
CH550814A (fr) 1974-06-28
IS2047A7 (is) 1972-06-16
FR2118078B1 (xx) 1975-08-01
NL174943C (nl) 1984-09-03
BE776683A (fr) 1972-06-14
DK141249B (da) 1980-02-11
DK141249C (xx) 1980-08-04
CH556860A (de) 1974-12-13
AT319235B (de) 1974-12-10
SE393381B (sv) 1977-05-09
IL38364A0 (en) 1972-02-29
ZM18971A1 (en) 1972-08-21

Similar Documents

Publication Publication Date Title
IE35897L (en) Azapurinones
IE32210L (en) Isothiocyanobenzazole derivatives
GB1448852A (en) Plant growth inhibiting diamino-5-nitropyrimidines
ES8307825A1 (es) "un procedimiento para preparar un compuesto de cefem".
GB1433920A (en) Alkanolamine derivatives
ES8105709A1 (es) Un procedimiento para la preparacion de derivados de azeti din-2-ona.
GB1154260A (en) N-Aromatically Substituted Acid Amides
GB1459506A (en) Piperidine derivatives
CA2059069A1 (en) Method for preparing n-fluoropyridinium salt
IE801703L (en) N-cyanoimidates
DE69302848D1 (de) Verfahren zur Herstellung von Guanidinderivativen
GB1438095A (en) 2-substituted-5,6-dimethoxyindazoles their preparation and compositions containing them
GB1346952A (en) Acylated acetarylamides their preparation and use as yellow colour couplers
BG100366A (en) Method for the preparation of substitued 4,6-diamino-5-cyanopyrimidines
GB1465667A (en) Thiono-thiol-phosphoric acid esters and ester-amides and their use as insecticides acaricides and nematicices
GB1139458A (en) 2-phenylamino-2-oxazolines and their production
JPS56120662A (en) Novel nitrosourea derivative and its preparation
SE7407493L (xx)
ES8603434A1 (es) Un procedimiento para la produccion del 1, 2, 4-triazolilpropanol
GB1433078A (en) Substituted phenethylamines
GB1146770A (en) S-triazolo[4,3-a]pyrazine derivatives
GB1359523A (en) Benzalacetone amidinohydrazone derivatives and the production thereof
GB1325787A (en) 6-aminomethyl-pyrimidines and a process for their production
JPS54106446A (en) Substituted alpha-aminophenylacetic acid
GR81771B (xx)